Changes in Psychological Distress During the COVID-19 Pandemic in Japan: A Longitudinal StudyOriginal Article Published on 2020-11-052022-10-30 Journal: Journal of Epidemiology [Category] COVID-19, SARS, [키워드] 95% CI 95% confidence interval age Analysis average baseline change changes changes in conducted COVID-19 COVID-19 infection COVID-19 pandemic develop early phase examined Factor Follow-up General population include individual Japanese Japanese people K6 likelihood longitudinal lowest measure mental health Novel coronavirus Odds ratio ordinal logistic regression percentage Protective Psychological distress Respiratory disease Result scale significant increase survey underlying diseases United State was measured was performed [DOI] 10.2188/jea.JE20200271 PMC 바로가기 [Article Type] Original Article
The Japanese version of the Fear of COVID-19 scale: Reliability, validity, and relation to coping behaviorResearch Article Published on 2020-11-052022-10-28 Journal: PLoS ONE [Category] COVID-19, MERS, SARS, [키워드] Anxiety arising aversion contribute coping behavior coping behaviors COVID-19 Depression Effect fear HADS health monitoring indicated Japan Japanese Japanese people participant Perceived platform positive correlation problems recruited reliability Result scale Seven significantly socio-demographic total effect Validity variables vulnerability [DOI] 10.1371/journal.pone.0241958 PMC 바로가기 [Article Type] Research Article
Serum KL-6 level is a useful biomarker for evaluating the severity of coronavirus disease 2019혈청 KL-6 수준은 코로나바이러스 질병 2019의 중증도를 평가하는 데 유용한 바이오마커입니다Article Published on 2020-11-012022-08-31 Journal: Respiratory investigation [Category] MERS, 바이오마커, [키워드] Biomarker category center Characteristics Comorbidities coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 severity Critical cut-off cut-off value diagnosed with COVID-19 Diagnosis died disease disease severity elevated enrolled evaluate examined groups Infection Japanese Krebs von den Lungen-6 median Mild moderate non-severe group Older Patient peak level peak levels Pneumonia radiological receiver operating characteristic Red sensitivity serum severe COVID-19 severe group severe or critical illness severity severity of COVID-19 significantly significantly higher specificity to define two group two groups U/mL Viral viral infection was used were used worsened [DOI] 10.1016/j.resinv.2020.07.004 PMC 바로가기 [Article Type] Article
Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case series일본 코로나19 관련 급성호흡곤란증후군에 의한 사이토카인 분비 증후군 환자에서 인터루킨 6 억제제 토실리주맙의 사용 증례 시리즈Article Published on 2020-11-012022-09-12 Journal: Respiratory investigation [Category] 진단, [키워드] acute respiratory distress case sery caused Cytokine release syndrome inhibitor Japanese Patient Tocilizumab [DOI] 10.1016/j.resinv.2020.09.006 PMC 바로가기 [Article Type] Article
Perception of COVID-19 Restrictions on Daily Life among Japanese Older Adults: A Qualitative Focus Group StudyArticle Published on 2020-11-012022-10-31 Journal: International journal for equity in health [Category] COVID-19, [키워드] activity age Analysis changes in community-dwelling older adults conducted contribute coronavirus disease COVID-19 Daily examined focus functional group Health inductive content analysis Infection Infection prevention Japan Japanese life mental health Older other disease pandemic participant Perception positive Previous studies Qualitative reduced reducing reported restriction rural urban was performed while [DOI] 10.3390/healthcare8040450 PMC 바로가기 [Article Type] Article
A real-time survey on the psychological impact of mild lockdown for COVID-19 in the Japanese populationData Descriptor Published on 2020-10-292022-10-29 Journal: Scientific Data [Category] Coronavirus, MERS, SARS, [키워드] addition age applied collected data conducted coronavirus disease country COVID-19 COVID-19 outbreak Environment Epidemiology Factor Final Government healthcare worker Homo sapien Japan Japanese location lockdown loneliness management Metadata Mild network analysis Psychological Psychological distress psychological Impact questionnaire recall bias reported Risk factors Sample Seven Sex socio-demographic Spread Stress technology women [DOI] 10.1038/s41597-020-00714-9 PMC 바로가기 [Article Type] Data Descriptor
Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer ResearchOriginal Article Published on 2020-10-212022-10-30 Journal: International journal of clinical oncology [Category] COVID-19, MERS, SARS, [키워드] cancer patient cancer treatment Care Chemotherapy Coronavirus disease 2019 COVID COVID-19 Efficacy foundation Gastrointestinal oncology global pandemic Health healthcare professionals implication Infection Japan Japanese managing medical resource morbidity and mortality oncologist oncology outlined pandemic Patient reduce risk of COVID-19 severe adverse events shown with COVID-19 World Health Organization [DOI] 10.1007/s10147-020-01806-7 PMC 바로가기 [Article Type] Original Article
Once-weekly vs. twice-weekly carfilzomib dosing in a subgroup of Japanese relapsed and refractory multiple myeloma patients from a randomized phase 3 trial (A.R.R.O.W.) and comparison with ENDEAVOROriginal Article Published on 2020-10-102024-09-04 Journal: International journal of hematology [Category] 대상포진, [키워드] Carfilzomib Japanese Kyprolis Once-weekly relapsed and refractory multiple myeloma [DOI] 10.1007/s12185-020-03013-6 PMC 바로가기 [Article Type] Original Article
COVID-19 with repeated positive test results for SARS-CoV-2 by PCR and then negative test results twice during intensive care: a case reportCase Report Published on 2020-10-072022-10-30 Journal: Journal of Medical Case Reports [Category] COVID-19, MERS, SARS, [키워드] acute respiratory syndrome Case report clinical clinical symptom Complete computed tomographic coronavirus coronavirus disease COVID-19 criteria Determining Diagnosis discharge Hospitalization initial Intensive intensive care Japanese management negative test Patient PCR polymerase chain positive positive test result repeat positivity/negativity repeated respiratory symptom reverse transcription RT-PCR SARS-CoV-2 [DOI] 10.1186/s13256-020-02534-2 PMC 바로가기 [Article Type] Case Report
A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trialLetter Published on 2020-10-022022-10-29 Journal: Trials [Category] COVID-19, MERS, SARS, [키워드] 1:1 Ability to communicate acute respiratory syndrome addition administration age Analysis antipyretics Arm Blinding calculated clinical clinical trial Combination common cold-like symptom control group coronavirus cough COVID-19 COVID-19 patient criteria decrease defined Dementia difficulty dissemination effective Efficacy element exclusion criteria fatigue female Fever Follow-up group H1N1 influenza hospitals Hypothesis IMPROVE in both group include Inclusion Infection Inpatient Japan Japanese Kampo Kampo medicines lactating less malaise Medicine Mild-to-moderate number objective occurred outcome Outpatient parallel-group participant Patient patients positive Prevention for severe stage previous study protocol Psychiatric random Randomized Randomized controlled trial receive recruited registry required Research Sample size SARS-CoV-2 Severe infection Severity of disease Shortness of breath significance level significantly sputum Stage steroid Study protocol survival survival curve Symptom Symptom relief symptomatic temperature the Kaplan-Meier method the log-rank test the median the primary endpoint the SARS-CoV-2 to define treated Treatment Two-arm website [DOI] 10.1186/s13063-020-04746-9 PMC 바로가기 [Article Type] Letter